Evidence map›Paper›PMID 35662841›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Biological Effects of Maslinic Acid on Human Epithelial Cells Used in Tissue Engineering.

Olimpia Ortiz-Arrabal, Jesús Chato-Astrain, Pascual Vicente Crespo, Ingrid Garzón, María Dolores Mesa-García, Miguel Alaminos, Carolina Gómez-Llorente

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Olimpia Ortiz-ArrabalTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada, Spain.
Jesús Chato-AstrainTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada, Spain.
Pascual Vicente CrespoTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada, Spain.
Ingrid GarzónTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada, Spain.
María Dolores Mesa-GarcíaInstituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain.
Miguel AlaminosTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada, Spain.
Carolina Gómez-LlorenteInstituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada · ESUniversidad de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present work, we evaluated the potential of maslinic acid (MA) to improve currently available keratinocyte culture methods for use in skin tissue engineering. Results showed that MA can increase cell proliferation and WST-1 activity of human keratinocytes after 24, 48, and 72 h, especially at the concentration of 5 μg/ml, without affecting cell viability. This effect was associated to a significant increase of KI-67 protein expression and upregulation of several genes associated to cell proliferation (PCNA) and differentiation (cytokeratins, intercellular junctions and basement membrane related genes). When human keratinocytes were isolated from skin biopsies, we found that MA at the concentration of 5 μg/ml significantly increased the efficiency of the explant and the cell dissociation methods. These results revealed the positive effects of MA to optimize human keratinocyte culture protocols for use in skin tissue engineering.

Indexed as

cell culturecell proliferationepithelial cellsmaslinic acidtissue engineering

Identifiers

PMID35662841
PMCPMC9159156
OpenAlexW4280574018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.